These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18605762)

  • 1. Immunohistochemistry of pulmonary and pleural neoplasia.
    Beasley MB
    Arch Pathol Lab Med; 2008 Jul; 132(7):1062-72. PubMed ID: 18605762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung.
    Di Loreto C; Puglisi F; Di Lauro V; Damante G; Beltrami CA
    Cancer Lett; 1998 Feb; 124(1):73-8. PubMed ID: 9500194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
    Brown RW; Clark GM; Tandon AK; Allred DC
    Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
    Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
    Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry: applications to the evaluation of lung and pleural neoplasms: part 2.
    Mani H; Zander DS
    Chest; 2012 Nov; 142(5):1324-1333. PubMed ID: 23131941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary adenocarcinoma simulating malignant mesothelioma.
    Tang P; Vatsia SK; Teichberg S; Kahn E
    Arch Pathol Lab Med; 2001 Dec; 125(12):1598-600. PubMed ID: 11735699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry: applications to the evaluation of lung and pleural neoplasms: part 1.
    Mani H; Zander DS
    Chest; 2012 Nov; 142(5):1316-1323. PubMed ID: 23131940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretının.
    Sahin N; Akatli AN; Celik MR; Ulutas H; Samdanci ET; Colak C
    Pathol Oncol Res; 2017 Jul; 23(3):487-491. PubMed ID: 27761727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Aquaporin-1 in lung adenocarcinomas and pleural mesotheliomas.
    López-Campos JL; Sánchez Silva R; Gómez Izquierdo L; Márquez E; Ortega Ruiz F; Cejudo P; Barrot Cortés E; Toledo Aral JJ; Echevarría M
    Histol Histopathol; 2011 Apr; 26(4):451-9. PubMed ID: 21360438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma.
    Chaouche-Mazouni S; Scherpereel A; Zaamoum R; Mihalache A; Amir ZC; Lebaïli N; Delaire B; Gosset P
    Ann Diagn Pathol; 2015 Aug; 19(4):193-7. PubMed ID: 25935651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: trends in Australia and a literature review.
    Linton A; Kao S; Vardy J; Clarke S; van Zandwijk N; Klebe S
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):273-9. PubMed ID: 23167246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous pulmonary carcinoma and pleural diffuse malignant mesothelioma.
    Allen TC; Moran C
    Arch Pathol Lab Med; 2006 May; 130(5):721-4. PubMed ID: 16683892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical diagnosis of epithelioid mesothelioma: an update.
    Ordóñez NG
    Arch Pathol Lab Med; 2005 Nov; 129(11):1407-14. PubMed ID: 16253021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miliary pulmonary metastases from a clinically occult pleural mesothelioma.
    Livasy CA; Tishko DJ; Maygarden SJ
    Ann Diagn Pathol; 2003 Aug; 7(4):249-53. PubMed ID: 12913849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura.
    Miettinen M; Sarlomo-Rikala M
    Am J Surg Pathol; 2003 Feb; 27(2):150-8. PubMed ID: 12548160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.